TCL Archive After 30 Years As NCI-Designated Center, Vermont Cancer Center Loses Core Grant. November 14, 2008
TCL Archive In Brief: VP-16 NDA Approved By FDA Only For Refractory Testicular Cancer; Removed From Group C List December 2, 1983
TCL Archive Pursuit Of Truth Was Not An NIH Objective In Gallo Case, Dingell Staff Report Says January 6, 1995